Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | F9 |
| Upstream (Parents) |
|---|
| (<<) PLG → F9 |
| (<<) AHSG → F9 |
| (<<) CFHR2 → F9 |
| Downstream (Children) |
|---|
| F9 → SLC2A2 (>>) |
| F9 → PLG///LPA (>>) |
| F9 → CYP2C8 (>>) |
| F9 → AHSG (>>) |
| F9 → CYP2C9 (>>) |
| F9 → AGXT (>>) |
| F9 → ITIH1 (>>) |
| F9 → ADH1A (>>) |
| F9 → CPS1 (>>) |
| F9 → ARG1 (>>) |
| F9 → ANGPTL3 (>>) |
| F9 → SLC22A1 (>>) |
| F9 → AFM (>>) |
| F9 → LIPC (>>) |
| F9 → UGT2B28 (>>) |
| F9 → CFHR2 (>>) |
| F9 → F13B (>>) |
| F9 → C8A (>>) |
| F9 → ALDH8A1 (>>) |
| F9 → AKR1C4 (>>) |
| F9 → MASP2 (>>) |
| F9 → SAA4 (>>) |
| F9 → PLGLB1///PLGLB2 (>>) |
| F9 → GCKR (>>) |
